Skip to content
healthcare.dev

REZZAYO

NDC 70842-240, rezafungin, injection, powder, lyophilized, for solution, from Melinta Therapeutics, LLC.

Product NDC
70842-240
Status
Listed
Labeler
Melinta Therapeutics, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217417
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70842-240 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REZAFUNGIN200 mg/1

Pharmacologic classes

Echinocandin Antifungal [EPC]; Lipopeptides [CS]

Package NDCNDC-11Package
70842-240-01708420240011 VIAL in 1 CARTON (70842-240-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/90073508-6dca-4d27-aa5a-ed837737c35b
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70842-240

Use it

Look up 70842-240 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70842-240 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70842-240. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.